These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25816209)

  • 1. An in silico insight into novel therapeutic interaction of LTNF peptide-LT10 and design of structure based peptidomimetics for putative anti-diabetic activity.
    Chavan SG; Deobagkar DD
    PLoS One; 2015; 10(3):e0121860. PubMed ID: 25816209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico molecular interaction analysis of LTNF peptide-LT10 with snake venom enzymes.
    Chavan SG; Deobagkar DD
    Protein Pept Lett; 2014 Jul; 21(7):646-56. PubMed ID: 24654849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
    Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
    Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of insulin fragments by insulin-degrading enzyme: the role of zinc(II) and cystine bridges.
    Bellia F; Pietropaolo A; Grasso G
    J Mass Spectrom; 2013 Feb; 48(2):135-40. PubMed ID: 23378084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-silico assessment of novel peptidomimetics inhibitor targeting STAT3 and STAT4 N-terminal domain dimerization: A comprehensive study using molecular docking, molecular dynamics simulation, and binding free energy analysis.
    Shree M; Vaishnav J; Gurudayal ; Ampapathi RS
    Biochem Biophys Res Commun; 2024 Nov; 733():150584. PubMed ID: 39208642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?
    Chen KC; Chang SS; Tsai FJ; Chen CY
    J Biomol Struct Dyn; 2013; 31(11):1219-35. PubMed ID: 23146021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of pathogenic non- synonymous genetic mutations of human insulin-degrading enzyme by in silico methods.
    Shaik NA; Kaleemuddin M; Banaganapalli B; Khan F; Shaik NS; Ajabnoor G; Al-Harthi SE; Bondagji N; Al-Aama JY; Elango R
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):517-32. PubMed ID: 24059301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning and Molecular Dynamics Based Insights into Mode of Actions of Insulin Degrading Enzyme Modulators.
    Jamal S; Goyal S; Shanker A; Grover A
    Comb Chem High Throughput Screen; 2017; 20(4):279-291. PubMed ID: 28137222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulations reveal a novel mechanism for ATP inhibition of insulin degrading enzyme.
    da Cruz CH; Seabra G
    J Chem Inf Model; 2014 May; 54(5):1380-90. PubMed ID: 24697863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel peptidomimetics bearing
    Tang XM; Hu W; Fan L; Wang H; Tang MH; Yang DC
    Future Med Chem; 2020 Jun; 12(11):991-1013. PubMed ID: 32208864
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity.
    Lasheen DS; Ismail MA; Abou El Ella DA; Ismail NS; Eid S; Vleck S; Glenn JS; Watts AG; Abouzid KA
    Bioorg Med Chem; 2013 May; 21(10):2742-55. PubMed ID: 23583031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilized β-Hairpin Peptide Inhibits Insulin Degrading Enzyme.
    Yang D; Qin W; Shi X; Zhu B; Xie M; Zhao H; Teng B; Wu Y; Zhao R; Yin F; Ren P; Liu L; Li Z
    J Med Chem; 2018 Sep; 61(18):8174-8185. PubMed ID: 30148634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
    Leissring MA; Malito E; Hedouin S; Reinstatler L; Sahara T; Abdul-Hay SO; Choudhry S; Maharvi GM; Fauq AH; Huzarska M; May PS; Choi S; Logan TP; Turk BE; Cantley LC; Manolopoulou M; Tang WJ; Stein RL; Cuny GD; Selkoe DJ
    PLoS One; 2010 May; 5(5):e10504. PubMed ID: 20498699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists.
    Swedberg JE; Schroeder CI; Mitchell JM; Durek T; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Liras S; Price DA; Craik DJ
    Eur J Med Chem; 2015 Oct; 103():175-84. PubMed ID: 26352676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-degrading enzyme is activated by the C-terminus of α-synuclein.
    Sharma SK; Chorell E; Wittung-Stafshede P
    Biochem Biophys Res Commun; 2015 Oct; 466(2):192-5. PubMed ID: 26343304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP/MALDI-MS complete characterization of the proteolytic fragments produced by the interaction of insulin degrading enzyme with bovine insulin.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2007 Dec; 42(12):1590-8. PubMed ID: 18085545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of peptidomimetics for inhibition of HER2 receptor dimerization by a combination of virtual screening, MD simulations, and QSAR in silico methods.
    Jamalan M; Zeinali M; Barzegari Asadabadi E
    Chem Biol Drug Des; 2013 Apr; 81(4):455-62. PubMed ID: 23006820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.